[Antibacterial therapy in the newborn infant].
D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D001414:Bacitracin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007239:Infections / Q000188:drug therapy*; D007612:Kanamycin / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D009675:Novobiocin / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011485:Protein Binding; D013203:Staphylococcal Infections / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010406:Penicillins; D011113:Polymyxins; D013449:Sulfonamides; D001414:Bacitracin; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D000666:Amphotericin B; D013752:Tetracycline; D009355:Neomycin; D002512:Cephalothin; D013307:Streptomycin
Antibakterielle Therapie beim Neugeborenen.